The cell-cycle inhibitor p21 is upregulated during senescence and upon induction of senescence-like arrest by oncogenic Ras. We have used primary ®broblasts derived from p21-null mice to evaluate the role of p21 in these processes. We ®nd that primary p21 , and by decreasing their proliferation rate. In agreement with this, p21 7/7 cells are refractory to neoplasic transformation by oncogenic Ras when compared to p53 7/7 cells. We conclude that, in murine ®broblasts, p21 is not essential neither for senescence nor for preventing neoplasic transformation by oncogenic Ras.
Introduction
Primary cells proliferate in culture for only a limited number of doublings. At the end of their lifespan, normal cells enter into a permanent growth-arrest known as cellular senescence (reviewed in Votja and Barrett, 1995) . In human cells, telomere attrition is directly implicated in triggering senescence (see for example Bodnar et al., 1998; Kiyono et al., 1998) ; but in rodent cells, senescence is independent of telomere shortening (Blasco et al., 1997; Carman et al., 1998; Russo et al., 1998) . Many tumor cells have the potential to proliferate inde®nitely. Indeed, the inactivation of some tumor suppressors is associated to a delay or cancellation of the senescence program, which suggests that senescence might be an antitumoral mechanism (reviewed in Garkavtsev et al., 1998) . In particular, there is strong evidence implicating the tumor suppressors p53 and p16
INK4a
in senescence (reviewed in Stein and Dulic, 1995; Garkavtsev et al., 1998) . The introduction of oncogenic Ras into primary cells elicits an antiproliferative response that resembles senescence and that is mediated by p53 and p16
INK4a (Serrano et al., 1997) . Accordingly, rodent cells de®cient in p53 or p16 are eciently transformed by oncogenic Ras (Serrano et al., 1997; Lloyd et al., 1997; Zhu et al., 1998; Lin et al., 1998) . This response has been interpreted as a defense mechanism to prevent oncogene-driven proliferation (reviewed in Weinberg, 1997) .
Protein p53 is a transcription factor activated in response to a number of stimuli, such as DNA damage and oncogenes (reviewed in Giaccia and Kastan, 1998) . The activation of p53 occurs through multiple and complex mechanisms that include stabilization against proteolytic degradation and association to other proteins (reviewed in Prives, 1998; Giaccia and Kastan, 1998) . In senescent human ®broblasts, the total levels of p53 do not change but its activity increases, as revealed by p53-speci®c assays for DNA binding and transcriptional activation (Rittling et al., 1986; Afshari et al., 1993; Atadja et al., 1995; Bond et al., 1996) . Loss of functional p53 allows an extension of the proliferative potential of human ®broblasts in culture (Rogan et al., 1995; Bond et al., 1995; Medclaf et al., 1996; Yan et al., 1996; Gallimore et al., 1997; Gire and Wynford-Thomas, 1998) . This extended proliferative life ends in a senescence-like arrest (Rogan et al., 1995; Medclaf et al., 1996; Gallimore et al., 1997) or in an apoptotic crisis (Bond et al., 1995) . In the case of murine ®broblasts, p53 must play also an important role in senescence because cells derived from p53-de®cient mice do not enter senescence (Harvey et al., 1993; Tsukada et al., 1993; Jones et al., 1996) , and because spontaneous immortalization of murine ®broblasts is frequently associated to mutation of p53 (Harvey and Levine, 1991; Rittling and Denhardt, 1992; Kamijo et al., 1997) . The activation of p53 at senescence might be mediated by the tumor suppressor p19 ARF , which is encoded by the same genetic locus as p16 INK4a (reviewed in Haber, 1997) and is upregulated during senescence (Kamijo et al., 1997) . Protein p19 ARF associates to p53 and to the p53-destabilizing protein MDM2, thus resulting in stabilization and activation of p53 (reviewed in Sherr, 1998 ; see also Pomerantz et al., 1998; Zhang et al., 1998; Kamijo et al., 1998; Stott et al., 1998) .
In addition to senescence, the expression of p19 ARF is also upregulated in response to several oncogenes, including oncogenic Ras, but not in response to DNA damage. Indeed, p19
ARF is essential for the stabilization of p53 induced by oncogenic stimuli de Stanchina et al., 1998; Bates et al., 1998; Palmero et al., 1998) . Altogether, these data have led to the concept that p19 ARF acts as a sensor of various oncogenic stimuli that activate p53 (reviewed in Sherr, 1998) .
Protein p21
Waf1/Cip1/Sdi1 is a general inhibitor of cyclindependent kinases implicated in the negative regulation of the cell-cycle (El-Deiry et al., 1993; Harper et al., 1993; Xiong et al., 1993; Noda et al., 1994; reviewed in Sherr and Roberts, 1995) . The protein levels of p21 are regulated transcriptionally, and this occurs both by p53-dependent and by p53-independent mechanisms. In response to g-radiation, p21 is strongly upregulated in a p53-dependent manner (see El-Deiry et al., 1993; Di Leonardo et al., 1994) , and cells derived from p21-null mice arrest ineciently upon g-radiation (Brugarolas et al., 1995; Deng et al., 1995) . On the other hand, p21 is upregulated in a p53-independent manner during several dierentiation processes and in response to TGFb (see Halevy et al., 1995; Macleod et al., 1995; Datto et al., 1995) . Protein p21 also has an important role on other aspects of proliferation, for example: p21-de®cient cells exhibit reduced growth-factor requirements ; ATM-de®cient cells proliferate poorly but this defect is rescued in combination with p21-de®ciency (Wang et al., 1997; Xu et al., 1998) ; and, ®nally, cells doubly de®cient for p21 and Rb have the ability to grow in soft-agar . Regarding tumorigenesis, p21-de®ciency does not increase signi®catively tumor formation (Deng et al., 1995) , although it accelerates spontaneous tumor appearance in combination with Rb +/7 / 
mutations (Serrano, unpublished observations) , and g-radiation-induced tumors in combination with ATM mutation (Wang et al., 1997) .
In senescent human ®broblasts, the levels of p21 are increased (Noda et al., 1994; Tahara et al., 1995; Alcorta et al., 1996) , together with those of other p53 transcriptional targets, such as IGFBP-3 (Goldstein et al., 1991; Buckbinder et al., 1995) . However, it is not well established which is the relative contribution of p53 in the upregulation of p21 during senescence (Bond et al., 1995; Tahara et al., 1995; Medclaf et al., 1996; Gallimore et al., 1997) . In addition to ®broblasts, the induction of p21 at senescence has been also observed in vascular endothelial cells (Watanabe et al., 1997) , but not in T-lymphocytes or epithelial cells from several tissues (Rezniko et al., 1996; Foster et al., 1998; Brenner et al., 1998; Erickson et al., 1998) . Notably, the analysis of a single p21 7/7 clone of human ®broblasts obtained after selection for two independent homologous recombination events has led to the conclusion that p21 is the critical target of p53 during senescence (Brown et al., 1997) .
Finally, p21 is upregulated in association with cellcycle arrest induced by constitutive activation of the Ras/Raf/MEK pathway (Serrano et al., 1997; Pumiglia and Decker, 1997; Sewing et al., 1997; Woods et al., 1997; Olson et al., 1998; Zhu et al., 1998; Lin et al., 1998) . The induction of p21 by the Ras/Raf/MEK pathway occurs with dierent kinetics and with dierent requirements of p53 depending on the particular experimental systems (see Discussion). Here, we have used primary mouse ®broblasts genetically de®cient in p21 (Brugarolas et al., 1995) to critically test the eect of p21-de®ciency in immortalization and in neoplasic transformation by oncogenic Ras.
Results

Immortalization of p21
7/7 MEFs
The ability of single cells to form visually-detectable colonies is partly dependent on their capacity to divide continuously. Consequently, it is possible to estimate the impact of a speci®c mutation on the proliferative potential by comparing colony-formation eciencies (see for example Harvey et al., 1993; Jones et al., 1996; Serrano et al., 1996) . We have measured the colonyforming eciencies of primary mouse embryo fibroblasts (MEFs) derived from wild-type mice or from mice carrying null mutations at the p21, p53, or INK4a/ARF loci, respectively (Table 1 ). It should be noted that the mutation present in the INK4a/ARF locus, deletion of exons 2 and 3, eliminates the function of p16 INK4a (Serrano et al., 1996) , but its eects on the function of p19 ARF have not been unambiguously determined (see Palmero et al., 1998) . As previously reported, wild-type MEFs formed colonies very ineciently compared to p53
MEFs, INK4a/ ARF D2,3 MEFs, or the immortal cell line of murine ®broblasts NIH3T3 (Harvey et al., 1993; Jones et al., 1996; Serrano et al., 1996) (see Table 1 ). Interestingly, the colony-formation eciency of p21 7/7 MEFs was very similar to that of wt MEFs (see Table 1 (Todaro and Green, 1963) . Under these conditions, wild-type cells proliferate vigorously during the ®rst 10 ± 15 population doublings and, then, enter a characteristic cell-cycle arrest known as senescence. During cultivation, rare immortal cells can appear stochastically that eventually overtake the senescent cells generating immortal oligoclonal cultures (Rittling, 1996) . We have performed two series of 3T3 cultivation assays: one series consisting of three independent isolates of each of the following genotypes, wild-type, p21 7/7 and INK4a/ ARF D2,3 ; and, a second series, consisting of three additional independent isolates of each of the abovementioned genotypes plus p53 7/7 MEFs. The pro®les of accumulated population doubling level (PDL) corresponding to the three wt and p21 7/7 cultures of the second 3T3 series are shown in Figure 1 (similar data were obtained from the ®rst 3T3 cultivation series). As reference, each panel includes the pro®les of one p53 7/7 culture and one INK4a/ARF D2,3 culture. Five of the six p21
cultures tested entered senescence, thus behaving similarly to wt cultures ( Figure 1 ; and results not shown). The p21 7/7 culture derived from embryo number 21 did not enter a detectable senescent phase (see Figure 1 , right panel); however, at passage 22, this culture had lost the expression of p16 (Figure 2 ), suggesting that it had undergone a selection process during cultivation. We interpret that in the particular case of p21 7/7 culture number 21 immortalization occurred at a very early passage, thus occluding the senescent phase. As expected, none of the primary p53 7/7 or INK4a/ ARF D2,3 MEFs manifested senescence (see Figure 1 ) (Harvey et al., 1993; Tsukada et al., 1993; Jones et al., 1996; Serrano et al., 1996) . These results indicate that absence of p21 does not result in full immortalization of murine ®broblasts.
Protein p21 levels during serial cultivation of MEFs
We have analysed the levels of protein p21 in MEFs of dierent genotypes and at three dierent stages: young', actively dividing, cells (passage P0; see Materials and methods for the de®nition of passage 0);`old' cells (P7-P9) which in the case of wt and p21 7/7 cells are mostly formed by senescent cells (PDL in the range of 12 ± 15); and`immortal', postsenescence, cultures (P22, corresponding to PDL420) (see Figure 1 ). In agreement with a previous report on murine ®broblasts (Mazars and Jat, 1997), protein p21 levels did not change signi®cantly between young (passage P0) and old (passage P9) wt MEFs ( Figure  2 ). Upon immortalization (passage P22), the levels of protein p21 slightly decreased in two of the wt cultures (D5 and E17), and were undetectable in wt culture D18. In this latter case, it was determined that loss of p21 is secondary to the inactivation of p53. The levels of p21 in p53 7/7 MEFs were almost undetectable (Deng et al., 1995) , but upon prolonged exposure it was possible to detect low amounts of p21 (Figure 2 ). In the case of INK4a/ARF D2,3 cells, p21 levels behaved as in wt MEFs. As a control to monitor the senescence process in murine ®broblasts (Palmero et al., 1997) , we have measured the levels of p16 INK4a . We observed that in all the wt, p21
7/7 and p53 7/7 cultures analysed, protein p16
INK4a levels were signi®cantly increased from passages P0 to P9.
Status of p53 and p16 in late-passage cultures
Spontaneous immortalization of wild-type primary MEFs is associated with the selection of clonal or oligo-clonal populations carrying immortalizing alterations which often aect p53 or p16 (Harvey and Levine, 1991; Rittling and Denhardt, 1992; . We have observed complete loss of p16 in Figure 1 Serial 3T3 cultivation of primary MEFs of dierent genotypes. Cultures derived from individual embryos (identi®ed by a number preceded or not by a letter) were cultivated according to the 3T3 protocol (see Materials and methods). The graph represents the accumulated number of doublings that each culture has undergone at every passage. All the cultures, both at the left and right panels, were carried in parallel together with others of p53 7/7 and INK4a/ARF D2,3 genotype that are not included for simplicity. Note that wt culture E17 did not generate an immortal culture Figure 2 Protein levels of the cell-cycle inhibitors p21 and p16
INK4a in young, senescent and immortal MEFs populations. Extracts were prepared at the indicated passage number from cultures derived from embryos of dierent genotypes, as indicated (see Figure  1) . In wt MEFs, passage 0 corresponds to young actively-proliferating cells, passage 9 corresponds to senescent cells, and passage 22 corresponds to spontaneously immortalized cells. Proteins were identi®ed by immunoblot (see Materials and methods). Note that wt culture E17 could not be analysed at late passage because it did not generate an immortal culture (see Figure 1) p21 in senescence and transformation C Pantoja and M Serrano cultures D5 and 21, originally derived from wt and p21 7/7 cultures, respectively ( Figure 2 ). As anticipated, none of the p53 7/7 late passage cultures lost p16 (Figure 2 ). To ascertain the functional status of p53, we evaluated the eect of DNA damage on the levels of p53 and p21. Treatment of late-passage cultures (between passages P25 and P30) with adriamycin resulted in a signi®cant accumulation of p53 in cultures D5 (derived from wt cells), 32 (p21
) and 21 (p21 7/7 ) ( Figure 3 ). The accumulation of p53 in culture D5 (wt) was accompanied by increased levels of p21 (Figure 3) . In contrast, the levels of p53 were constitutively high in culture D18 (wt) and p21 was almost undetectable; in the case of culture 27 (p21
), we could not identify a normal p53 band (Figure 3) . We conclude that these two cultures, D18 (wt) and 27 (p21
), do not have a functional p53. As anticipated, the three late-passage INK4a/ARF D2,3 cultures retained functional p53 according to this assay ( Figure 3) ; also, no induction of p21 by adriamycin was observed in the p53
cultures (not shown). In summary, most immortalized wt and p21 7/7 cultures (four out of ®ve) acquired alterations in either p53 or p16, in a mutually exclusive manner (Table 2 ). Culture number 32 (originally derived from p21 7/7 MEFs) was the only exception (Table 2 ). In the absence of a more extensive study it is not possible to decide whether this case is indicative of a weak immortalizing eect of p21-de®ciency, or whether other alterations dierent than p53 or p16 are present. None of the p53 7/7 or INK4a/ ARF D2,3 cultures seemed to acquire additional alterations at late passage. Altogether, we conclude that p21-de®cient MEFs require additional mutations for immortalization and, therefore, p21-de®ciency is not sucient by itself to allow immortalization.
Eect of oncogenic Ras on the proliferation of p21 7/7 MEFs Constitutive Ras signaling provokes a delayed cellcycle arrest reminiscent of senescence and dependent on the upregulation of p53, p16
INK4a and p19 ARF (Serrano et al., 1997; Palmero et al., 1998) . To characterize the role of p21 in this process, we have analysed the eect of retrovirally-transduced oncogenic ras (H-rasV12) on the levels of p21 in primary cells of dierent genotypes. We observed an upregulation of p21 in response to oncogenic Ras in both wt and
MEFs ( Figure 4 ). (Although the experiment shown in Figure 4 suggests that the endogenous levels of p21 and p53 are lower in the INK4a/ARF D2,3 MEFs compared to wt MEFs, we have not observed this consistently). In the case of p21
MEFs, we observed accumulation of both p53 and p16
INK4a (Figure 4 ), thus indicating that these changes do not require the presence of p21. Of note, the levels of expression of oncogenic Ras attained by our retroviral vectors were approximately 2 ± 3 times the endogenous Ras levels (Figure 4) .
We have also compared the proliferative activity of the dierent cultures in the absence or presence of oncogenic Ras ( Figure 5 ). In agreement with previous observations (Serrano et al., 1997; Lin et al., 1998) , oncogenic Ras stimulated the proliferation of p53
7/7
Figure 3 Eect of adriamycin on the stabilization of p53 and the induction of p21 in late-passage cultures. Cultures were treated or not with adriamycin, as indicated (see Materials and methods). Extracts were prepared from late-passage cultures (P25-P30), except in the case of the culture labeled`18' which corresponds to a primary early-passage culture. Proteins were identi®ed by immunoblot (see Materials and methods). Note that wt culture E17 is not analysed because it did not generate an immortal culture (see Figure 1 ) n.a. , in primary MEFs of dierent genotypes. Early-passage MEFs of the indicated genotypes were infected with retroviruses containing an empty vector (V) or oncogenic Ras (see Materials and methods). Extracts were prepared on day 0 after infection and selection (the 6th day since the beginning of the infection; see Materials and methods; see also Serrano et al., 1997) . The antibody used to detect Ras, pan-Ras, detects endogenous Ras proteins (H-, K-, and N-Ras) and ectopically expressed oncogenic Ras p21 in senescence and transformation C Pantoja and M Serrano and INK4a/ARF D2,3 MEFs, and produced morphological changes characteristic of neoplasic transformation such as rounded cellular bodies with thin cytoplasmic projections (not shown). In contrast, wt and p21 7/7 cells transduced with oncogenic Ras had a diminished proliferative potential relative to their counterparts transduced with empty vector (Figure 5 ). We conclude that p21 is not essential for the anti-proliferative response elicited by moderate levels of oncogenic Ras.
Transformation properties of p21 7/7 MEFs
In general, the proliferation arrest induced by oncogenic Ras in primary wt MEFs does not occur as rapidly and eciently as in primary human ®broblasts and, therefore, wt MEFs expressing oncogenic Ras retain a low proliferative activity even 10 days after infection of the cells (see Figure 5 ). To con®rm that this residual proliferation is not due to transformation of a small proportion of cells, we plated the cells in soft-agar to evaluate their growth in the absence of attachment. As shown in Figure 6 , primary p21 7/7 MEFs expressing oncogenic Ras were unable to form colonies in soft-agar, whereas Ras-expressing INK4a/ARF
D2,3
MEFs formed colonies. This is in contrast to MEFs doubly de®cient for Rb and p21 which are able to grow in soft-agar, although they are not tumorigenic . Also, we performed colony-formation assays on regular culture plates to evaluate the possible immortalization of some p21 7/7 cells by Ras, but we obtained the same colonyforming eciencies in the absence (see Table 1 ) or presence of Ras (results not shown).
We have further evaluated the role of p21 in protecting cells against transformation by performing classical focus-formation assays using calcium-phosphate transfection. As previously reported (Serrano et al., 1996 (Serrano et al., , 1997 , primary p53 7/7 and INK4a/ARF
MEFs were susceptible to transformation by oncogenic Ras (Figure 7 and Table 3 ). In contrast, p21 7/7 cells were resistant to transformation by oncogenic ras, thus behaving like wt MEFs (Figure 7 and Table 3 ). These results reinforce the suggestion that p21-de®cient cells are protected against oncogenic transformation by Ras.
Discussion
In this work, we have characterized the behavior of primary p21
7/7
®broblasts with respect to their immortalization and transformation properties.
We have critically evaluated the role of p21 in senescence by analysing the proliferation of p21 7/7 cells during serial cultivation. Murine ®broblasts genetically de®cient in p21 enter senescence in a manner similar to wt cells, and in sharp contrast to the behavior of p53 7/7 cells. We have derived a total of ®ve immortal cultures from wt and p21 7/7 primary cultures, and we have observed that immortalization was accompanied in most cases (four out of ®ve) by loss of functional p53 or by loss of p16, in a mutually exclusive manner. As anticipated, late passage p53 7/7 cultures retained p16 and, conversely, late passage INK4a/ARF D2,3 cultures retained p53. A similar association between loss of p53 and loss of p16 has been previously reported . Altogether, we conclude that p21 is not essential for the establishment of senescence in murine ®broblasts, and that spontaneous immortalization of p21 7/7 primary cells still requires Figure 5 Eect of retrovirally-transduced oncogenic Ras on the proliferation of primary MEFs of dierent genotypes. Proliferation rates were measured by the incorporation of radioactivelylabeled thymidine into the DNA of cells infected with empty viruses or with viruses containing oncogenic ras (see Materials and methods). The bars indicate the percentage of proliferation in the presence of oncogenic ras, considering 100% the amount of thymidine incorporation in the corresponding cells infected with an empty vector. Proliferation was measured on day 4 after infection and selection (the 10th day since the beginning of the infection; see Materials and methods; see also Serrano et al., 1997) . The data correspond to the average and standard deviation of three independent assays, in each assay thymidine incorporation was measured in triplicates Figure 6 Colony-formation in soft-agar of primary MEFs of dierent genotypes retrovirally-transduced with oncogenic Ras. Cells infected with empty viruses or with viruses containing oncogenic ras, as indicated, were plated on soft-agar on day 6 after infection and selection (the 12th day since the beginning of the infection; see Materials and methods; see also Serrano et al., 1997) . The ®gure shows representative ®elds. All the pictures were taken at the same magni®cation (1006), except the one corresponding to INK4a/ARF D2,3 MEFs transduced with oncogenic Ras that was taken at lower magni®cation (406) p21 in senescence and transformation C Pantoja and M Serrano additional immortalizing mutations. It is possible that several p53 targets, including p21, cooperate during senescence, but neither of them individually has an essential role. In this regard, it has been reported that high p21 is not sucient to maintain the senescent phenotype in human ®broblasts (Bond et al., 1995) . Notably, the analysis of a single p21 7/7 clone of human ®broblasts obtained after selection for two independent homologous recombination events has led to the conclusion that p21 is essential for senescence (Brown et al., 1997) . Considering the robustness of the senescence program in human cells compared to murine cells, it is unexpected that de®ciency of p21 can abrogate senescence in human cells but not in murine cells. Alternatively, the above-mentioned clone of human p21 7/7 cells could contain additional alterations that contribute to the cancellation of senescence.
We have reported that moderate expression of oncogenic Ras is initially mitogenic and, after a relatively long period (6 ± 10 days), results in a senescence-like arrest (Serrano et al., 1997; Lin et al., 1998) . This arrest is dependent on the activation of both the p19 ARF /p53 and the p16 INK4a /Rb pathways (Serrano et al., 1997; Lin et al., 1998; Palmero et al., 1998) . Consistent with the activation of the p19 ARF /p53 pathway, p21 levels are also upregulated upon introduction of oncogenic Ras (Serrano et al., 1997; Lin et al., 1998; this report) . In the absence of p53, the residual basal levels of p21 are almost undetectable even after transduction of oncogenic Ras (not shown). We ®nd that p21-de®cient ®broblasts retain the antiproliferative response elicited by oncogenic Ras, including the activation of p53 and p16
INK4a
. Furthermore, p21-de®cient ®broblasts are not eciently transformed by oncogenic Ras, and this is in contrast to p53 7/7 cells that are eciently transformed. These results indicate that p21 is not essential for the antiproliferative response induced by moderate levels of oncogenic Ras, and that p21-de®cient ®broblasts are refractory to transformation. Regarding other cell types dierent than ®broblasts, it should be mentioned that there are con¯ictive reports about the susceptibility of p21-de®cient keratinocytes to be transformed by oncogenic Ras (Missero et al., 1996; Weinberg et al., 1997) .
Other investigators have characterized the eect of fusions between Raf and the hormone-binding domain of nuclear receptors on the proliferation of ®broblasts (Pumiglia and Decker, 1997; Sewing et al., 1997; Woods et al., 1997; Zhu et al., 1998) . Under these conditions, activation of Raf produces a high-intensity mitogenic signaling that leads to a rapid cell-cycle arrest (*16 h) accompanied by a dramatic induction of p21. There are important mechanistic dierences between this proliferation arrest and the one produced under our experimental conditions. Speci®cally, the cell-cycle arrest produced by acute Raf activation in primary murine ®broblasts is p53-independent but p21-dependent (Sewing et al., 1997; Woods et al., 1997) . Moreover, high-intensity Raf signaling also results in cell-cycle arrest in murine NIH3T3 ®broblasts (Pumiglia and Decker, 1997; Sewing et al., 1997; Woods et al., 1997) , implicating that this arrest is independent of proteins p19 ARF and p16 INK4a (NIH3T3 cells are known to have sustained a deletion of the INK4a/ARF locus, see for example Kamijo et al., 1997) . In contrast to the eects of acute Raf activation, Figure 7 Transformation susceptibility of primary MEFs of dierent genotypes by oncogenic Ras. Early-passage MEFs were transfected by the calcium-phosphate method with a plasmid expressing oncogenic Ras under an LTR promoter (see Materials and methods). Three weeks after transfection, plates were stained to reveal the presence of neoplasic foci. The ®gure shows a representative experiment (see Table 3 ) ) and C24 (INK4a D2,3 ); assay number 2, with donor embryos D4 (wt), 29 (p21 7/7 ), F1 (p53
) and C24 (INK4a the cell-cycle arrest that we have studied here is produced by the long-term eects (6 ± 10 days) of proliferation under the in¯uence of moderate levels of Ras. Our results do not exclude that p21-de®cient ®broblasts expressing Ras could have some proliferative advantage that can be manifested in other type of assays. In this regard, it has been reported that during the initial mitogenic period that follows retroviral transduction of oncogenic Ras there is an accelerated proliferation of p21-de®cient ®broblasts compared to wt ®broblasts (Sewing et al., 1997) .
We would like to emphasize the parallelism between the results obtained here and the tumor phenotype of some mutant mice. Hence, mice de®cient in p53 or INK4a/ARF are prone to develop tumors (Donehower et al., 1992; Jacks et al., 1994; Serrano et al., 1996; Kamijo et al., 1997) , and cells derived from these mice are highly susceptible to neoplasic transformation (Tanaka et al., 1994; Metz et al., 1995; Serrano et al., 1996 Serrano et al., , 1997 Kamijo et al., 1997; Palmero et al., 1998) . In contrast, p21-de®cient mice are not tumor prone (Deng et al., 1995) , and cells derived from them are refractory to transformation by oncogenic Ras (this report). These observations do not exclude a partial role for p21 in tumorigenesis and, indeed, p21-de®ciency accelerates spontaneous tumor appearance in combination with mutations in Rb or in INK4a/ARF D2,3 (Serrano, unpublished observations) , and g-radiation-induced tumors in combination with mutated ATM (Wang et al., 1997) . In summary, we conclude that, in murine ®broblasts, p21 is not essential neither for senescence, nor for resistance to transformation by oncogenic Ras.
Materials and methods
Cell culture
Primary mouse embryo ®broblasts (MEFs) were derived from day 13.5 embryos obtained from the corresponding colonies of wild-type, p21 7/7 (Brugarolas et al., 1995) , p53 7/7 (Jacks et al., 1994) , and INK4a/ARF D2,3 (Serrano et al., 1996) mice maintained at the CNB, Madrid, in a mixed genetic background C57BI/6; 129/Sv. MEFs were prepared essentially as described (Serrano et al., 1997) . Brie¯y, each embryo was dispersed and trypsinized in a 10 cm diameter plate and the resulting cells were incubated for 1 or 2 days until con¯uent. Attached cells were then transferred to a 15 cm diameter plate and incubated for 2 days. At this point, most of the attached cells had the appearance of ®broblasts. These cells were frozen in aliquots and considered passage 0 (P0). NIH3T3 cells were obtained from Dr Ana C Carrera (CNB, Madrid, Spain). BOSC cells were used for packaging ecotropic retroviruses (Pear et al., 1993) . All the abovementioned cells were grown in Dulbecco's modi®ed Eagle's medium (DMEM; GIBCO) supplemented with 10% fetal bovine serum (FBS; SIGMA).
For colony-formation assays, 6610 3 cells were distributed on a total of three dishes of 10 cm diameter and incubated in DMEM plus 10% FBS. After 2 weeks of incubation with regular changes of medium every 3 days, dishes were stained with Giemsa, and the number of visible colonies (41.5 mm of diameter) was scored.
Serial 3T3 cultivation was done as described (Todaro and Green, 1963) . Brie¯y, 10 6 cells were plated on 10 cm diameter dishes, 3 days later the total number of cells in the dish were counted, and 10 6 cells were replated again. This procedure was repeated for 25 passages. The increase in population doubling level (DPDL), was calculated according to the formula DPDL=log(n f /n 0 )/log2, where n 0 is the initial number of cells and n f is the ®nal number of cells.
For To evaluate the functional status of p53, 10 6 cells were plated on 10 cm diameter dishes and, after 20 ± 24 h, adriamycin was added to a ®nal concentration of 0.5 mg/ml (water soluble adriamycin was obtained from Pharmacia), for 6 h. Cell extracts were prepared and processed for immunoblotting as indicated below.
For colony-formation in soft agar, 3610 5 cells were resuspended in DMEM plus 10% FBS containing 0.3% low melting-point agarose (LMP agarose; BioRad), and plated onto 6 cm diameter dishes coated with 0.5% LMP agarose in complete medium. Plates were incubated for 2 weeks at 378C and supplemented once a week with 1 ml of complete medium containing 0.3% LMP agarose. The presence of colonies was determined by observation under the microscope.
Retroviral transduction
Retroviral gene transfer was performed using high-titer retroviral stocks generated by transient transfection of the BOSC ecotropic packaging cell line (Pear et al., 1993) with a pBabe-puro vector (Morgenstern and Land, 1990) containing the human H-rasV12 oncogene, as previously described (Serrano et al., 1997) . Viral supernatants were used to infect early-passage MEFs (P0-P1). Twenty-four hours after infection, infected cells were selected for 3 days in the presence of 2.5 mg/ml puromycin, and plated on the 5th day post-infection for the corresponding assays; the 6th day since the beginning of the infection was called day 0 (see Serrano et al., 1997) .
Immunoblotting
Extracts were prepared by lysing the cells on lysis buer (Tris-HCl 50 mM, pH 7.5; 150 mM NaCl; NP-40 0.5%; 1 mM phenylmethylsulfonyl¯uoride, 2 mg/ml aprotinin, 2 mg/ml leupeptin, 1 mg/ml pepstatin). After 10 min on ice, cellular debris were removed by centrifugation at 12 000 r.p.m. for 10 min. Protein concentration was measured using BioRad DC Protein Assay Kit. Samples corresponding to 40 mg of protein were resolved on 15% SDS ± PAGE gels, wettransferred to nitrocellulose (BioRad) and immunoblotted. For detection of p16, we used polyclonal antibody M-156 (1 : 1000 dilution) (Santa Cruz); for p21, polyclonal antibody C-19 (1 : 100) (Santa Cruz); for p53, we used either monoclonal antibody PAb240 (1 : 300) (Calbiochem) ( Figure  3 ) or polyclonal antibody CM5 (1 : 200) (Novocastra) ( Figure  4) ; for Ras, monoclonal antibody pan-ras (Ab-3) (1 : 200) (Oncogene Science); and for b-actin, monoclonal antibody AC-15 (1 : 10 000) (Sigma). As secondary antibodies, we used a dilution 1 : 1000 of either HRP-linked anti-rabbit (Amersham) or HRP-linked anti-mouse (DAKO). Detection was performed by chemiluminescence using ECL (Amersham).
Focus formation assay
Early-passage MEFs (P0-P1) derived from individual embryos were seeded (10 6 cells) in plates of 10 cm diameter and cultured overnight in complete medium containing 10% FBS. The medium was changed 1 h before transfections p21 in senescence and transformation C Pantoja and M Serrano began. For these assays, we used oncogenic H-rasV12 under an LTR promoter in vector pBabe-puro (Morgenstern and Land, 1990; Serrano et al., 1997) . Transfections were done by a standard calcium-phosphate procedure with 10 mg of pBabe-puro-H-rasV12 plus 20 mg of carrier DNA plasmid (empty pBabe-puro). After 8 h of incubation with the precipitates, the incubation medium was changed and, 18 h later, cells were distributed equally into three 10 cm diameter plates. Dishes were refed with fresh medium every 3 days. At day 21 post-transfection, cells were ®xed and stained with Giemsa, and the total number of foci in the three plates was scored.
